Both a DEA lawyer and an FDA official spoke to justify rescheduling—arguments that were condemned by a prominent ...

The DEA begins reviewing its proposal to move cannabis to Schedule III, even as reform advocates criticize their exclusion ...

The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The ...

The Drug Enforcement Administration is scheduled to hold a historic hearing beginning Monday, June 29, 2026, which could ...

The Drug Enforcement Agency has published a new final rule adjusting the fee schedule for its Diversion Control Program, which includes a more than 30 percent increase in the registration fee assessed ...

Sens. Mark Warner, D-Va., and Sheldon Whitehouse, D-R.I., are urging the Drug Enforcement Administration to extend federal telemedicine flexibilities for prescribing controlled substances before they ...

O-DSMT is the primary active metabolite in tramadol, a synthetic opioid approved by the Food and Drug Administration to treat ...

Announced April 22, 2026, and effective April 28, 2026, the Justice Department (Attorney General) and the Drug Enforcement Administration (DEA) issued an order that rescheduled certain types of ...

A change in federal law governing controlled substances went into effect in March and has left the Mount Desert Fire ...

This is the sixth and final installment in a six-part series examining major federal law enforcement agencies through a ...